"Bilirubin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bile pigment that is a degradation product of HEME.
| Descriptor ID |
D001663
|
| MeSH Number(s) |
D03.383.129.578.840.249.184 D03.633.400.909.249.184 D04.345.783.249.184 D23.767.193.184
|
| Concept/Terms |
Bilirubin, Calcium Salt- Bilirubin, Calcium Salt
- Calcium Salt Bilirubin
- Salt Bilirubin, Calcium
- Calcium Bilirubinate
- Bilirubinate, Calcium
|
Below are MeSH descriptors whose meaning is more general than "Bilirubin".
Below are MeSH descriptors whose meaning is more specific than "Bilirubin".
This graph shows the total number of publications written about "Bilirubin" by people in this website by year, and whether "Bilirubin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 9 | 20 | 29 |
| 2018 | 12 | 11 | 23 |
| 2019 | 3 | 3 | 6 |
| 2020 | 3 | 11 | 14 |
| 2021 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Bilirubin" by people in Profiles.
-
The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities. Eur J Gastroenterol Hepatol. 2021 12 01; 33(1S Suppl 1):e274-e281.
-
A new parameter for predict the clinical outcome of patients with COVID-19 pneumonia: The direct/total bilirubin ratio. Int J Clin Pract. 2021 Oct; 75(10):e14557.
-
COVID-19 and liver injury: a meta-analysis. Eur J Gastroenterol Hepatol. 2021 07 01; 33(7):990-995.
-
A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis. Biomaterials. 2021 08; 275:120986.
-
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity. Sci Adv. 2021 05; 7(22).
-
The sex-related discrepancy in laboratory parameters of severe COVID-19 patients with diabetes: A retrospective cohort study. Prim Care Diabetes. 2021 08; 15(4):713-718.
-
Cautions on the laboratory indicators of COVID-19 patients on and during admission. J Clin Lab Anal. 2021 May; 35(5):e23767.
-
Prognostic value of bilirubin and drug interactions. BMJ Open Gastroenterol. 2021 05; 8(1).
-
Evaluation of hepatic enzymes activities in COVID-19 patients. Int Immunopharmacol. 2021 Aug; 97:107701.
-
Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-analysis. Hepatology. 2021 04; 73(4):1521-1530.